eli lilly retatrutide study stock jumps on Phase 3 weight loss results Eli Lilly's Next-Gen Obesity Drug

When to adjust your stack Consider modifying your protocol when side effects persist beyond initial adaptation of 1-2 weeks, expected results are not materializing after appropriate timeframe, blood work shows concerning changes, goals shift and current peptides no longer align, or cost becomes unsustainable for the benefits received

Tirzepatide (Mounjaro/Zepbound): Clinical studies demonstrated even greater reductions, averaging around 20% or more of body weight

For metabolic dysfunction where liver fat is driving risk, retatrutides mechanism may prove more relevant but that awaits outcome trials

Section 3: How Does Semaglutide Affect Thyroid Function